Transdermal Drug Delivery: Principles and Applications

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/111

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

112 Terms

1
New cards

Transdermal Drug Delivery

Method delivering drugs through skin to bloodstream.

2
New cards

Topical Drug Delivery

Method delivering drugs to local skin tissue.

3
New cards

Systemic Absorption

Drug absorption into systemic circulation.

4
New cards

Ideal Drug Characteristics

Specific properties for effective transdermal delivery.

5
New cards

Dose Deliverable

Maximum dose for transdermal delivery, < 10 mg/day.

6
New cards

Aqueous Solubility

Required solubility for transdermal drugs, > 1 mg/ml.

7
New cards

Lipophilicity

Optimal range for transdermal drugs, 101 < Ko/w < 105.

8
New cards

pH of Saturated Solution

Ideal pH range for transdermal drugs, pH 5-9.

9
New cards

Molecular Weight

Ideal weight for transdermal drugs, < 500 Da.

10
New cards

Melting Point

Ideal melting point for transdermal drugs, < 200°C.

11
New cards

Bioavailability

Extent and rate at which active drug is absorbed.

12
New cards

First-Pass Metabolism

Liver metabolism reducing drug bioavailability.

13
New cards

Short t1/2 Drugs

Drugs with short half-lives, e.g., nitroglycerin.

14
New cards

Rotigotine

Only marketed drug developed for transdermal delivery.

15
New cards

Transdermal Patch Components

Ingredients in patches for effective drug delivery.

<p>Ingredients in patches for effective drug delivery.</p>
16
New cards

Patient Counseling

Guidelines for safe use of transdermal formulations.

17
New cards

Permeation Enhancers

Substances improving drug absorption through skin.

18
New cards

Skin Anatomy

Structure of skin relevant to drug delivery.

<p>Structure of skin relevant to drug delivery.</p>
19
New cards

Conventional Topical Preparations

Traditional methods for local drug application.

20
New cards

Transdermal Preparations

Formulations designed for systemic drug delivery.

21
New cards

Market Trends

Forecast for transdermal drug delivery market growth.

22
New cards

Challenges in Delivery

Issues affecting reliability of transdermal products.

23
New cards

Steady plasma level

Consistent drug concentration in bloodstream.

24
New cards

Parenteral administration

Drug delivery via injection, bypassing gastrointestinal tract.

25
New cards

Therapeutic effect termination

Ability to quickly stop drug effects.

26
New cards

Patient compliance

Ease of use leading to better adherence.

27
New cards

Potent PK control

Enhanced management of pharmacokinetics for effective dosing.

28
New cards

Transdermal route limitations

Only suitable for potent drugs, not all.

29
New cards

Molecular weight restriction

High molecular weight drugs cannot penetrate skin.

30
New cards

Skin irritants

Drugs causing irritation are unsuitable for patches.

31
New cards

Slow onset action

Delayed therapeutic effects, unsuitable for emergencies.

32
New cards

Patch adhesion issues

Varied skin types affect patch stickiness.

33
New cards

Drug disposal concerns

Residual drug in patches complicates disposal.

34
New cards

Moisture exposure effects

Sweating reduces patch adhesion effectiveness.

35
New cards

Backing layer

Provides flexibility and appearance to the patch.

36
New cards

Drug reservoir

Contains drug with excipients in reservoir systems.

37
New cards

Membrane function

Encloses drug layer, forming a pouch.

38
New cards

Pressure sensitive adhesive (PSA)

Adhesive layer, typically drug-free in reservoir systems.

39
New cards

Release liner

Protective layer removed before patch application.

40
New cards

Permeation enhancer

Substances that improve skin permeability for drugs.

<p>Substances that improve skin permeability for drugs.</p>
41
New cards

Application site preparation

Skin must be clean, dry, and hair-free.

42
New cards

Patch rotation

Changing application sites to prevent irritation.

43
New cards

Heat exposure precautions

Avoid excessive heat to maintain patch effectiveness.

44
New cards

Crystallization issue

Prolonged storage can cause drug crystallization.

45
New cards

Non-medicated adhesive tape

Used to secure patches for extended wear.

46
New cards

Residual drug delivery

Patches often leave significant drug amounts after use.

47
New cards

Skin irritation causes

Active and inactive ingredients may provoke reactions.

48
New cards

Transdermal Patch

A drug delivery system applied to skin.

49
New cards

Buprenorphine

Used for moderate to chronic pain relief.

50
New cards

Capsaicin

Management of neuropathic pain via patch.

51
New cards

Clonidine

Treats hypertension; available in various doses.

52
New cards

Diclofenac

Short-term pain relief for sprains and bruises.

53
New cards

Estradiol

Hormone therapy for menopause symptoms.

54
New cards

Fentanyl

Reservoir patch for chronic pain management.

55
New cards

Granisetron

Antinauseant for chemotherapy patients.

56
New cards

Lidocaine

Local anesthetic delivered via patch.

57
New cards

Methylphenidate

Treats ADHD; delivered over 9 hours.

58
New cards

Nicotine

Smoking cessation aid via transdermal system.

59
New cards

Nitroglycerin

Treats angina pectoris; various release rates.

60
New cards

Oxybutynin

Antispasmodic for bladder control issues.

61
New cards

Rivastigmine

Used for Alzheimer's disease management.

62
New cards

Selegiline

Antidepressant available in multiple doses.

63
New cards

Scopolamine

Prevents motion sickness via transdermal patch.

64
New cards

Testosterone

Replaces low endogenous testosterone levels.

65
New cards

Iontophoresis

Delivers ionic drugs using electric current.

66
New cards

Heat Effects

Increases drug absorption through skin.

67
New cards

Patch Disposal

Follow specific instructions to prevent reuse.

68
New cards

Patient Consultation

Educate on proper patch application and risks.

69
New cards

MRI Precautions

Metal in patches can cause burns.

70
New cards

Cathode

Electrode that attracts positive ions in iontophoresis.

71
New cards

Anode

Electrode that attracts negative ions in iontophoresis.

72
New cards

Iontophoresis

Technique using electric current to deliver drugs transdermally.

73
New cards

Advantages of Iontophoresis

Noninvasive, minimizes trauma, local action with minimal absorption.

74
New cards

Disadvantages of Iontophoresis

Requires trained professional, potential skin irritation, higher cost.

75
New cards

Electrode Defect

Risk of overdose due to cathode-generated hydroxide.

76
New cards

pH in Iontophoresis

Affects drug ionization; optimal at pH 5 for HCl salts.

77
New cards

Current Density

Must be less than 0.5 MA/cm² to prevent burns.

78
New cards

Extraneous Ions

Compete with drugs, negatively affecting iontophoresis efficiency.

79
New cards

Fentanyl Iontophoretic Patch

Withdrawn in 2009 due to safety concerns after 2006 approval.

80
New cards

Sumatriptan Delivery

Approved in 2013, uses lithium batteries for controlled delivery.

81
New cards

Zecuity

Sumatriptan device, must be removed before MRI.

82
New cards

Electroporation

Experimental method using high voltage pulses to enhance skin permeability.

83
New cards

Phonophoresis

Ultrasound creates microjets to enhance drug delivery through skin.

84
New cards

Microneedles

Tiny needles pierce skin to facilitate drug transport.

85
New cards

Chemical Permeation Enhancers

Substances that temporarily reduce skin barrier permeability.

86
New cards

Skin Irritation

Adverse effect of iontophoresis; can cause discomfort.

87
New cards

Cost Effectiveness

Iontophoresis is more expensive than topical formulations.

88
New cards

Current Intensity

Electric current strength impacting drug delivery safety.

89
New cards

Metal Electrodes

Commonly used electrodes that alter solution pH.

90
New cards

Microjets

High-speed fluid jets created by imploding bubbles in phonophoresis.

91
New cards

Stratum Corneum

Outer skin layer targeted by various drug delivery methods.

92
New cards

Enhancers

Substances that improve drug permeability in skin.

93
New cards

Lipid-protein-partitioning theory

Explains how enhancers affect drug absorption.

94
New cards

Lipid lamellae

Layers of lipids in skin affecting permeability.

95
New cards

Keratin modification

Enhancers alter keratin structure for hydration.

96
New cards

Stratum corneum

Outer skin layer where drugs partition.

97
New cards

USP-NF

United States Pharmacopeia and National Formulary.

98
New cards

Apparatus 5

Paddle over disk method for drug release testing.

99
New cards

Apparatus 6

Cylinder method for evaluating drug release.

100
New cards

Apparatus 7

Reciprocating holder for drug release assessment.